Cisco Systems, Inc. R&D increased by 0.9% to $2.38B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.8%, from $2.34B to $2.38B. Over 4 years (FY 2021 to FY 2025), R&D shows an upward trend with a 9.2% CAGR.
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
research_and_development| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.70B | $1.71B | $1.71B | $1.67B | $1.71B | $1.68B | $1.78B | $1.86B | $1.96B | $1.95B | $1.91B | $1.94B | $1.95B | $2.18B | $2.29B | $2.30B | $2.34B | $2.38B | $2.40B | $2.36B | $2.38B |
| QoQ Change | — | +0.9% | +0.1% | -2.6% | +2.3% | -1.5% | +5.9% | +4.2% | +5.8% | -0.5% | -2.0% | +1.6% | +0.3% | +11.9% | +4.9% | +0.6% | +1.6% | +1.9% | +0.8% | -1.9% | +0.9% |
| YoY Change | — | — | — | — | +0.6% | -1.8% | +3.9% | +11.1% | +14.9% | +16.1% | +7.4% | +4.7% | -0.7% | +11.6% | +19.5% | +18.3% | +19.9% | +9.2% | +5.0% | +2.4% | +1.8% |